Science & Medicine

Update on Jakafi Open Letter


Good morning… Here’s the new Facebook notice re Jakafi pricing.  We’ll be posting it within the hour.  There’s been a strong response from the MPN community — patients, caregivers  and physicians.  If you get a chance, go to the page and read some of the 150+ comments to get a sense of how vital this issue is for us.  And, if you haven’t already, please consider signing with your name and location or adding a comment right in the REPLY box on the page.

Thanks, have a great week,





Prof. Hagop Kantarjian, M.D., Chairman, Department of Leukemia, MD Anderson,  is the principal author of the Blood letter signed by  100+ hematologists appealing for a reduction in the unsustainably high price of blood cancer drugs.

 Leukemia team


Now we can join the campaign. Patients and caregivers can sign the Open Letter to Incyte           

Comments on: "Update on Jakafi Open Letter" (1)

  1. Sandy Serpell said:

    Thankfully my health insurance provider approved Jakafi for treatment of my Myelofibrosis. Otherwise I would not be able to afford Jakafi. Please bring down the cost of this drug, so those not as fortunate as I, can have the option of taking Jakafi. There are so few options for those of us with MPNs, it’s a shame that cost is the prohibiting factor.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: